CAMBRIDGE, England & WALTHAM, Mass.--(BUSINESS WIRE)--Abcam plc ("Abcam," "Company," "Group") (Nasdaq: ABCM), a global leader in the supply of life science research tools, today filed and mailed a ...

As British research supplies and tools provider Abcam moves toward a potential multibillion-dollar sale, one of the company's founders and major shareholders is pushing back. Dr. Jonathan Milner, an ...

(Reuters) - Danaher Corp on Monday agreed to buy protein consumables manufacturer Abcam Plc in a $5.7 billion all-cash deal including debt, as the medical tools supplier looks to expand its portfolio ...

Abcam (LON:ABC) has had a rough month with its share price down 11%. It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative sentiment.

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -Abcam shareholders on Monday approved the proposal from Danaher Corp to acquire all outstanding shares of the company ...

Abcam PLC (NASDAQ:ABCM) is a $3.8 billion market cap biotechnology stock on the Nasdaq Global Select Market. It is moving its primary listing from Londons AIM (previously known as the Alternative ...

Sept 14 (Reuters) - Abcam Plc founder Jonathan Milner on Thursday said he would vote against medical tools supplier Danaher's (DHR.N), opens new tab proposed $5.7 billion acquisition of the company, ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. In 2022, Cambridge biotech Abcam decided that it preferred a US listing to a UK one. Now after a short stint on ...

CAMBRIDGE, England, Oct. 27, 2021 /PRNewswire/ -- Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the successful completion of its acquisition of ...